Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

RVNC

Revance Therapeutics, Inc.

Healthcare

Set alert

Price alert · RVNC

All alert types
3.65 0.00 0.00%
As of Feb 6, 2025
3.65 Day range 3.65

52-week range unavailable

YTD
+20.07%
1 year
-39.37%
Open
3.65
Prev close
3.65
Mkt cap
320.48M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
3.65
High
3.65
Forward P/E
-3.23
Beta
0.95
Short ratio
5.20
Inst. own
82.89%
Dividend
0.00
Ex-div date
50-d avg
4.37
200-d avg
4.37
1y target
7.64

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RVNC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-6.26 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.3×
FY 2014: -5.2×FY 2015: -11.3×FY 2016: -6.5×FY 2017: -8.9×FY 2018: -5.1×FY 2019: -4.5×FY 2020: -5.8×FY 2021: -3.8×FY 2022: -3.8×FY 2023: -2.3×
FY 2014 5y median -3.8× FY 2023
P/S 3.2×
FY 2014: 858×FY 2015: 2770×FY 2016: 1940×FY 2017: 4107×FY 2018: 195×FY 2019: 1708×FY 2020: 107×FY 2021: 14.2×FY 2022: 10.1×FY 2023: 3.2×
FY 2014 5y median 14.2× FY 2023
P/B -4.9×
FY 2014: 1.9×FY 2015: 3.3×FY 2016: 3.3×FY 2017: 4.0×FY 2018: 5.0×FY 2019: 3.1×FY 2020: 4.4×FY 2021: 16.1×FY 2022: 107×FY 2023: -4.9×
FY 2014 5y median 4.4× FY 2023
P/FCF -3.3×
FY 2014: -5.3×FY 2015: -14.1×FY 2016: -9.2×FY 2017: -11.0×FY 2018: -6.5×FY 2019: -6.4×FY 2020: -9.0×FY 2021: -4.6×FY 2022: -6.2×FY 2023: -3.3×
FY 2014 5y median -6.2× FY 2023
EV/EBITDA -3.7×
FY 2014: -3.2×FY 2015: -9.1×FY 2016: -6.0×FY 2017: -6.7×FY 2018: -4.8×FY 2019: -3.6×FY 2020: -5.2×FY 2021: -5.2×FY 2022: -5.5×FY 2023: -3.7×
FY 2014 5y median -5.2× FY 2023
EV/Sales 4.6×
FY 2014: 420×FY 2015: 2127×FY 2016: 1746×FY 2017: 3035×FY 2018: 176×FY 2019: 1365×FY 2020: 87.6×FY 2021: 16.9×FY 2022: 12.5×FY 2023: 4.6×
FY 2014 5y median 16.9× FY 2023
FCF Yield -30.1%
FY 2014: -18.9%FY 2015: -7.1%FY 2016: -10.9%FY 2017: -9.1%FY 2018: -15.3%FY 2019: -15.5%FY 2020: -11.1%FY 2021: -21.7%FY 2022: -16.1%FY 2023: -30.1%
FY 2014 5y median -16.1% FY 2023

Profitability

Gross Margin 35.0%
FY 2014: 100.0%FY 2015: -565.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: -2380.6%FY 2019: -24805.8%FY 2020: 68.9%FY 2021: 69.9%FY 2022: 61.0%FY 2023: 35.0%
FY 2014 5y median 61.0% FY 2023
Operating Margin -135.4%
FY 2014: -13590.1%FY 2015: -24105.7%FY 2016: -29405.0%FY 2017: -45963.4%FY 2018: -3825.0%FY 2019: -39820.6%FY 2020: -1782.5%FY 2021: -353.1%FY 2022: -205.3%FY 2023: -135.4%
FY 2014 5y median -353.1% FY 2023
Net Margin -138.4%
FY 2014: -16427.4%FY 2015: -24492.0%FY 2016: -29756.7%FY 2017: -46025.6%FY 2018: -3823.2%FY 2019: -37824.9%FY 2020: -1840.7%FY 2021: -368.7%FY 2022: -268.9%FY 2023: -138.4%
FY 2014 5y median -368.7% FY 2023
ROE 213.7%
FY 2014: -35.7%FY 2015: -29.0%FY 2016: -50.4%FY 2017: -44.9%FY 2018: -97.9%FY 2019: -69.3%FY 2020: -75.4%FY 2021: -418.9%FY 2022: -2828.7%FY 2023: 213.7%
FY 2014 5y median -75.4% FY 2023
ROIC -79.2%
FY 2014: -28.1%FY 2015: -27.1%FY 2016: -46.9%FY 2017: -43.5%FY 2018: -73.4%FY 2019: -54.3%FY 2020: -40.8%FY 2021: -58.6%FY 2022: -53.2%FY 2023: -79.2%
FY 2014 5y median -54.3% FY 2023
ROA -67.7%
FY 2014: -32.7%FY 2015: -26.6%FY 2016: -43.7%FY 2017: -40.8%FY 2018: -63.0%FY 2019: -45.9%FY 2020: -39.2%FY 2021: -54.0%FY 2022: -61.3%FY 2023: -67.7%
FY 2014 5y median -54.0% FY 2023

Growth (YoY)

Revenue 76.5%
FY 2014: -37.9%FY 2015: -21.7%FY 2016: 0.0%FY 2017: -12.7%FY 2018: 1323.3%FY 2019: -88.9%FY 2020: 3610.7%FY 2021: 407.7%FY 2022: 70.4%FY 2023: 76.5%
FY 2014 FY 2023
Operating Income -16.4%
FY 2014: -36.2%FY 2015: -38.9%FY 2016: -22.0%FY 2017: -36.5%FY 2018: -18.4%FY 2019: -15.3%FY 2020: -66.1%FY 2021: -0.6%FY 2022: 0.9%FY 2023: -16.4%
FY 2014 FY 2023
EPS (diluted) 21.8%
FY 2014: -9.5%FY 2015: 6.8%FY 2016: -5.3%FY 2017: -26.1%FY 2018: 1.7%FY 2019: 8.9%FY 2020: -35.4%FY 2021: 12.6%FY 2022: -15.3%FY 2023: 21.8%
FY 2014 FY 2023
Free Cash Flow -3.2%
FY 2014: -14.4%FY 2015: 4.9%FY 2016: -7.3%FY 2017: -54.8%FY 2018: -13.6%FY 2019: 1.7%FY 2020: -67.0%FY 2021: -31.1%FY 2022: 9.6%FY 2023: -3.2%
FY 2014 FY 2023

Financial Health

Current Ratio 3.8×
FY 2014: 16.9×FY 2015: 21.1×FY 2016: 9.8×FY 2017: 13.6×FY 2018: 6.5×FY 2019: 7.2×FY 2020: 7.4×FY 2021: 3.7×FY 2022: 5.0×FY 2023: 3.8×
FY 2014 5y median 5.0× FY 2023
Quick Ratio 3.3×
FY 2014: 16.8×FY 2015: 21.0×FY 2016: 9.8×FY 2017: 13.6×FY 2018: 6.5×FY 2019: 7.2×FY 2020: 7.3×FY 2021: 3.5×FY 2022: 4.7×FY 2023: 3.3×
FY 2014 5y median 4.7× FY 2023
Debt / Equity -3.2×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 4.7×FY 2022: 33.2×FY 2023: -3.2×
FY 2014 5y median 0.1× FY 2023
Net Debt / EBITDA -1.2×
FY 2014: 3.3×FY 2015: 2.7×FY 2016: 0.7×FY 2017: 2.4×FY 2018: 0.5×FY 2019: 0.9×FY 2020: 1.2×FY 2021: -0.8×FY 2022: -1.0×FY 2023: -1.2×
FY 2014 5y median -0.8× FY 2023
Interest Coverage -16.4×
FY 2014: -4.9×FY 2015: -60.8×FY 2016: -81.5×FY 2017: -264×FY 2018: -3242×FY 2019: 0.0×FY 2020: -18.0×FY 2021: -43.8×FY 2022: -16.5×FY 2023: -16.4×
FY 2014 5y median -16.5× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31